Showing results (351-360 of 536) with videos related to
Sort By:
Pageof 54
Developmental Medicine and Child Neurology|May 17, 2022
The subtypes of developmental coordination disorderJessica M Lust, Bert Steenbergen, Johanna Ankie E M Diepstraten, et al.Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.Alzheimer'S & Dementia (New York, N. Y.)|November 3, 2018
Online study partner-reported cognitive decline in the Brain Health RegistryRachel L Nosheny, Monica R Camacho, Philip S Insel, et al.Psychophysiology|June 7, 2021
Individual differences in attentional lapses are associated with fiber-specific white matter microstructure in healthy adultsAdam Clemente, Juan F Domínguez D, Phoebe Imms, et al.Biological Psychiatry|February 18, 2019
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B12, B6, and Folic Acid on Symptoms and Neurocognition in First-Episode PsychosisKelly Allott, Patrick D McGorry, Hok Pan Yuen, et al.Psychiatry Research|September 5, 2006
Evaluating brain activity in obsessive-compulsive disorder: preliminary insights from a multivariate analysisBen J Harrison, Murat Yücel, Marnie Shaw, et al.Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.Epilepsy & Behavior : E&B|February 9, 2025
Cognitive function at the time of focal epilepsy diagnosis is not associated with treatment resistanceJacob Pellinen, Stefan Sillau, Chris Morrison, et al.Current Alzheimer Research|December 24, 2013
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's diseaseRichard A Grove, Conn M Harrington, Andreas Mahler, et al.Neurobiology of Aging|January 7, 2015
APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's diseaseYen Ying Lim, Victor L Villemagne, Robert H Pietrzak, et al.Pageof 54